Murasugi Akira
Product Development Department, Meiji Dairies Corporation, 1-2-10, Shin-suna, Koto-ku, Tokyo 136-8908, Japan.
Recent Pat Biotechnol. 2010 Jun;4(2):153-66. doi: 10.2174/187220810791110679.
The heterologous protein expression system of Pichia pastoris is now widely used for expression of many human proteins, because the efficiently expressed proteins will be correctly folded in Pichia pastoris cells and also efficiently secreted from the cells. Recombinant human serum albumin (rHSA) is efficiently secreted from Pichia pastoris. Nowadays, the expression of rHSA exceeds 10g in 1 L fermentor culture broth, and the protein is completely purified. Recombinant HSA expressed in Pichia pastoris was approved as a medicine by the authorities in 2007, and launched in 2008 in Japan. One of the insulin precursors (IP) was also successfully expressed in Pichia pastoris, and secreted up to 3.6g in 1 L medium using a multi-copy transformant. The insulin precursor could be efficiently converted to insulin, the final product, in vitro. Human growth hormone was also expressed in Pichia pastoris, and secreted up to 49 mg in 1 L medium. These proteins are also important for clinical applications. Midkine and pleiotrophin may be two of the candidates for clinical applications. Secretion signals, the copy number of an expression cassette in transformants, and culture conditions for fermentation were examined for efficient expression of these proteins in Pichia pastoris. The best signal was selected, and other factors were optimized. The amounts of native midkine and native pleiotrophin expressed were approximately 0.36g and 0.26g in 1 L medium, respectively. Expression of bile-salt stimulated lipase (BSSL) had been extremely low in the beginning of a fermentor culture experiment. However, approximately 1 g rBSSL in 1 L medium was finally expressed in a fermentor by unlimited feeding of glycerol for cell growth and optimization of other factors. BSSL from human milk and rBSSL from Pichia cells are glycosylated. The structure differences between these glycans are obvious. When humanization of Pichia glycans is established by genetic engineering, the Pichia pastoris expression system will become indispensable for the production of therapeutic proteins.
毕赤酵母的异源蛋白表达系统目前被广泛用于多种人类蛋白的表达,因为在毕赤酵母细胞中高效表达的蛋白会正确折叠,并且能有效地从细胞中分泌出来。重组人血清白蛋白(rHSA)能从毕赤酵母中高效分泌。如今,在1 L发酵罐培养液中rHSA的表达量超过10 g,并且该蛋白已被完全纯化。2007年,毕赤酵母中表达的重组HSA被相关部门批准作为一种药物,并于2008年在日本上市。其中一种胰岛素前体(IP)也在毕赤酵母中成功表达,使用多拷贝转化体在1 L培养基中分泌量高达3.6 g。该胰岛素前体在体外能够有效地转化为最终产物胰岛素。人生长激素也在毕赤酵母中表达,在1 L培养基中分泌量高达49 mg。这些蛋白对于临床应用也很重要。中期因子和多效生长因子可能是临床应用的候选者之一。为了在毕赤酵母中高效表达这些蛋白,研究了分泌信号、转化体中表达盒的拷贝数以及发酵的培养条件。选择了最佳信号,并对其他因素进行了优化。在1 L培养基中,天然中期因子和天然多效生长因子的表达量分别约为0.36 g和0.26 g。在发酵罐培养实验开始时,胆汁盐刺激脂肪酶(BSSL)的表达极低。然而,通过为细胞生长无限量添加甘油并优化其他因素,最终在发酵罐中1 L培养基中表达了约1 g重组BSSL。人乳中的BSSL和毕赤酵母细胞中的重组BSSL都进行了糖基化修饰。这些聚糖之间的结构差异很明显。当通过基因工程实现毕赤酵母聚糖的人源化时,毕赤酵母表达系统将成为生产治疗性蛋白不可或缺的工具。